Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07VAI
|
|||
| Former ID |
DIB004529
|
|||
| Drug Name |
ALZ-801
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1], [2] | |
| Company |
Alzheon
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H18N2O4S
|
|||
| Canonical SMILES |
CC(C)C(C(=O)NCCCS(=O)(=O)O)N
|
|||
| InChI |
1S/C8H18N2O4S/c1-6(2)7(9)8(11)10-4-3-5-15(12,13)14/h6-7H,3-5,9H2,1-2H3,(H,10,11)(H,12,13,14)/t7-/m0/s1
|
|||
| InChIKey |
NRZRFNYKMSAZBI-ZETCQYMHSA-N
|
|||
| CAS Number |
CAS 1034190-08-3
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Oral Clinical Candidate ALZ-801 in Alzheon's pipeline. 2012. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.